Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2025